Get Started

AIMV

PINK AI Maverick Intel, Inc.
Oct 23, 2026 · 7:46 PM ET EOD Market Closed

$0.1300 ↑ +0.0701 (+117.03%) Trading Up from the previous close of $0.0599, and at the day’s high of $0.1300

YTD change
+333.33%
vs 20-day SMA
+33.26%
vs 200-day SMA
N/A

Price ranges

Previous day
$0.1300 $0.1300
open $0.1300 close $0.1300
+$0.0000 (+0.00%)
Today
$0.1300 $0.1300
open $0.1300 now $0.1300
+$0.0000 (+0.00%)
Past week
$0.0126 $0.0900
from $0.0412 now $0.1300
+$0.0888 (+215.53%)
Past month
$0.0126 $0.1700
from $0.1497 now $0.1300
-$0.0197 (-13.16%)
This year
$0.0126 $0.2900
from $0.0300 now $0.1300
+$0.1000 (+333.33%)

Price & Performance

+0.04 (+44.44%) / 6M

$0.0022$0.1052$0.2083$0.3113Apr 24Jul 23Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 55.2% away from all-time highs of $0.2900
  • AIMV is up 333% since the beginning of the year
  • AIMV is up 333% over the past 12 months
  • AIMV is down 13% over the past 1 month

AIMV reads very good: the 12-month move is +271.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0026
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $8.6M
Beta -1.27

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
Debt$21.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $6.3M

AI Maverick Intel, Inc. operates as a medical device company. It develops and markets innovative medical devices and technologies for the orthopedic and pain management markets. The company was founded on October 20, 1997 and is headquartered in Beverly Hills, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.